Integrating phosphoproteomics into the clinical management of prostate cancer


Phosphoproteomic analysis of tumor samples has the potential to uncover significant insights into kinase signaling networks present in late stage prostate cancer that are complementary to genomic and transcriptomic approaches. Phosphoproteomics could potentially aid drug development in clinical trial design as well as provide utility for oncologists in the… (More)
DOI: 10.1186/s40169-017-0138-5


1 Figure or Table

Slides referencing similar topics